Clinical Trials Browser

Recruiting × Interventional × CPG-oligonucleotide × Clear all

NCT04952272 2024-06-26

Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid Tumors

Phase 1 Recruiting

GastrointestinalThoracic

Carcinoma, Hepatocellular, Lung Neoplasms